1 citations
,
October 2025 in “Colorectal Disease” In this study, cancer patients aged 30 to 50 reported experiencing diagnostic delays, coping through self-advocacy, and facing stigma-related challenges such as alopecia. The authors concluded that improved physician awareness, tailored screening, and addressing stigma are essential for enhancing care for early-onset colorectal cancer patients.
September 2025 in “Journal of the American Academy of Dermatology” This study explores patients' perceptions of hair loss treatments, specifically oral minoxidil, topical minoxidil, and oral finasteride, building on existing clinical research.
December 2023 in “bioRxiv (Cold Spring Harbor Laboratory)” In this study, researchers used a computational drug repurposing approach to identify FDA-approved drugs Dutasteride and Solifenacin as potential inhibitors of Listeria monocytogenes via binding to the virulence factor regulator PrfA, suggesting they may offer new treatment strategies against multi-drug resistant strains.
July 2026 in “JMIR Dermatology” This study analyzed online discussions and search behavior in Gulf countries, uncovering significant engagement and identifying gaps in awareness and understanding of alopecia areata among patients and healthcare professionals, suggesting a need for targeted educational initiatives to enhance support and reduce stigma.
6 citations
,
October 2017 in “Oncotarget” In this study, NIH hairless mice showed increased susceptibility to Listeria monocytogenes infection compared to NIH mice, potentially due to differences in gut microbiota and monocyte levels.